Antibody targeting of TIRC7 results in significant therapeutic effects on collagen-induced arthritis in mice

N Utku, T Heinemann, M Winter, C G Bulwin, M Schlawinsky, P Fraser, E E S Nieuwenhuis, H-D Volk, R S Blumberg

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

TIRC7 is a cell surface molecule which is expressed in T and B lymphocytes and negatively regulates their function. Anti-TIRC7 specific monoclonal antibody (mAb) inhibited T cell memory response to recall antigens. Up-regulation of TIRC7 on lymphocytes from joint tissue of patients with Rheumatoid Arthritis (RA) and mice with collagen induced arthritis (CIA) suggested TIRC7 as a novel target to promote anti-inflammatory reaction. Anti-TIRC7 mAb administration significantly inhibited the induction and progression of CIA and the anti-collagen IgG1 and IgG2a antibody response. Combination therapy of anti-TIRC7 mAb and soluble TNF-alpha receptor demonstrated an increased inhibitory effect over the single compounds on CIA. The results demonstrate the therapeutic potential of TIRC7 targeting with mAb in diseases associated with exaggerated T and B cell responses.

Original languageEnglish
Pages (from-to)142-51
Number of pages10
JournalClinical and Experimental Immunology
Volume144
Issue number1
DOIs
Publication statusPublished - Apr 2006

Keywords

  • Animals
  • Antibodies, Monoclonal
  • Arthritis, Experimental
  • Arthritis, Rheumatoid
  • B-Lymphocytes
  • Female
  • Humans
  • Immunoglobulin G
  • Immunologic Memory
  • Immunotherapy
  • Knee Joint
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Receptors, Tumor Necrosis Factor
  • Synovial Fluid
  • T-Lymphocytes
  • Tumor Necrosis Factor-alpha
  • Up-Regulation
  • Vacuolar Proton-Translocating ATPases

Fingerprint

Dive into the research topics of 'Antibody targeting of TIRC7 results in significant therapeutic effects on collagen-induced arthritis in mice'. Together they form a unique fingerprint.

Cite this